Enabling CROs, pharma, healthcare and lifesciences industries with disruptive e-signature and smart document solutions Read more
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated lipoprotein(a) Read more
PharmaLytica Expo to aid in chalking out pharma industry’s $130 billion growth story by 2030 Read more